Literature DB >> 1629625

Buschke-Ollendorff syndrome associated with elevated elastin production by affected skin fibroblasts in culture.

M G Giro1, M Duvic, L T Smith, R Kennedy, R Rapini, F C Arnett, J M Davidson.   

Abstract

Buschke-Ollendorff syndrome (BOS; McKusick 16670) is an autosomal dominant connective-tissue disorder characterized by uneven osseous formation in bone (osteopoikilosis) and fibrous skin papules (dermatofibrosis lenticularis disseminata). We describe two patients in whom BOS occurred in an autosomal dominant inheritance pattern. The connective tissue of the skin lesions showed both collagen and elastin abnormalities by electron microscopy. Cultured fibroblasts from both patients produced 2-8 times more tropoelastin than normal skin fibroblasts in the presence of 10% calf serum. Involved skin fibroblasts of one patient produced up to eight times normal levels, whereas apparently uninvolved skin was also elevated more than threefold. In a second patient, whose involvement was nearly complete, elastin production was high in involved areas and less so in completely involved skin. Transforming growth factor-beta 1 (TGF beta 1), a powerful stimulus for elastin production, brought about similar relative increases in normal and BOS strains. Basic fibroblast growth factor, an antagonist of TGF beta 1-stimulated elastin production, was able to reduce elastin production in basal and TGF beta 1 stimulated BOS strains. Elastin mRNA levels were elevated in all patient strains, suggesting that Buschke-Ollendorff syndrome may result, at least in part, from abnormal regulation of extracellular matrix metabolism that leads to increased steady-state levels of elastin mRNA and elastin accumulation in the dermis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629625     DOI: 10.1111/1523-1747.ep12616769

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Authors:  Michael P Whyte; Malachi Griffith; Lee Trani; Steven Mumm; Gary S Gottesman; William H McAlister; Kilannin Krysiak; Robert Lesurf; Zachary L Skidmore; Katie M Campbell; Ilana S Rosman; Susan Bayliss; Vinieth N Bijanki; Angela Nenninger; Brian A Van Tine; Obi L Griffith; Elaine R Mardis
Journal:  Bone       Date:  2017-04-21       Impact factor: 4.398

2.  A Report of a Novel Pathogenic Variant in a Family with Buschke-Ollendorf Syndrome.

Authors:  Angita Jain; Pavalan Selvam; Herjot Atwal; Paldeep S Atwal
Journal:  J Pediatr Genet       Date:  2019-08-26

3.  Analysis of dermal elastic fibers in the absence of fibulin-5 reveals potential roles for fibulin-5 in elastic fiber assembly.

Authors:  Jiwon Choi; Andreas Bergdahl; Qian Zheng; Barry Starcher; Hiromi Yanagisawa; Elaine C Davis
Journal:  Matrix Biol       Date:  2009-03-24       Impact factor: 11.583

Review 4.  Buschke-Ollendorff syndrome in a grande multipara: a case report and short review of the literature.

Authors:  H M Al Attia; A M Sherif
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Transforming growth factor-beta reverses a posttranscriptional defect in elastin synthesis in a cutis laxa skin fibroblast strain.

Authors:  M C Zhang; M Giro; D Quaglino; J M Davidson
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

6.  The Buschke-Ollendorff syndrome: a case report of simultaneous osteo-cutaneous malformations in the hand.

Authors:  Michael Brodbeck; Q Yousif; P A Diener; M Zweier; J Gruenert
Journal:  BMC Res Notes       Date:  2016-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.